gi-hepatology
Revised Original International Autoimmune Hepatitis Score (IAIHG)
The revised original scoring system from the International Autoimmune Hepatitis Group (IAIHG) for diagnosing autoimmune hepatitis (AIH). Unlike the simplified score (which is point-of-care), the revised original score uses detailed serological, histological, and treatment response data. Pre-treatment score above 15 = definite AIH; 10-15 = probable AIH. Developed by Alvarez et al. 1999.
References
- Alvarez F et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31(5):929-938.
- EASL Clinical Practice Guidelines: Autoimmune Hepatitis. J Hepatol. 2015;63(4):971-1004.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Azathioprine · Systemic Immunosuppressant — Eczema / Autoimmune Dermatoses
- Natalizumab · Disease-Modifying Therapy — MS (Anti-VLA-4 Monoclonal Antibody)
- Prednisolone (Rheumatology) · Corticosteroid (oral) — bridge/anti-inflammatory
- Inebilizumab (Anti-CD19 — IgG4-Related Disease) · Anti-CD19 Monoclonal Antibody (B-Cell Depleting)
- Trimetazidine · Metabolic Anti-Anginal
- Isotretinoin · Systemic retinoid (Vitamin A derivative) / Anti-acne
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.